Instil Bio Inc
TIL
NASDAQ
Biotechnology
$7.38
USD
+0.11 (+1.51%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $49.30M
Volume 13.5K
Revenue
$2.24M
TTM
-47.5%
YoY
Gross Margin
100%
TTM
0.0%
YoY
Net Income
$-47.38M
TTM
+39.3%
YoY
Operating Cash Flow
$-33.76M
TTM
+25.8%
YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 |
|---|---|---|---|---|---|
Revenue | 0.0 | 0.0 | 2.2 | 0.0 | 0.0 |
YoY Growth | — | — | +50.2% | -100.0% | — |
Cost of Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross Profit | 0.0 | 0.0 | 2.2 | 0.0 | 0.0 |
Selling, General & Administrative | 9.1 | 6.2 | 5.9 | 0.0 | 5.3 |
Other Operating Expenses | 16.1 | 0.5 | 0.0 | 0.0 | 1.0 |
Total Operating Expenses | 30.6 | 23.4 | 15.0 | 0.0 | 7.0 |
Operating Income | -30.6 | -23.4 | -12.8 | 0.0 | -7.0 |
EBITDA | -14.0 | -22.9 | -12.8 | 0.0 | -6.0 |
Other Income / Expense | 2.3 | 2.6 | -0.1 | 0.0 | 3.7 |
Total Other Income / Expense | 2.4 | 2.0 | -0.8 | 0.0 | 2.8 |
Income Before Income Taxes | -28.2 | -21.4 | -13.6 | 0.0 | -4.2 |
Income Taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Net Income | -28.2 | -21.4 | -13.6 | -8.2 | -4.2 |
Consolidated Net Income / Loss | -28.2 | -21.4 | -13.6 | 0.0 | -4.2 |
Net Income Attributable to Common Shareholders | -28.2 | -21.4 | -13.6 | 0.0 | -4.2 |
Basic EPS | -$4.32 | -$3.24 | -$2.01 | $0.00 | -$0.62 |
Diluted EPS | -$4.32 | -$3.24 | -$2.01 | $0.00 | -$0.62 |
Basic Shares Outstanding | 6.5M | 6.6M | 6.8M | 6.8M | 6.8M |
Diluted Shares Outstanding | 6.5M | 6.6M | 6.8M | 6.8M | 6.8M |